Lost Money on V.F. Corporation (VFC)? Contact Levi & Korsinsky to Join Class Action Before November 12, 2025
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your V.F. Corporation (NYSE: VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=171096&wire=5&utm_campaign=20 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-06 5:02 PM EDT
Securities Class Action Lawsuit Filed Against Fortinet, Inc. (FTNT) - Levi & Korsinsky Represents Shareholders
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your Fortinet, Inc. (NASDAQ: FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=171095&wire=5&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-06 4:53 PM EDT
ATTENTION AS Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 6, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Amer Sports, Inc. ("Amer Sports, Inc.") (NYSE: AS) concerning possible violations of federal securities laws. On September 19, 2025, Amer's flagship brand Arc'teryx conducted a promotional fireworks display in Tibet, prompting a backlash from environmentalists and triggering an investigation by Chinese authorities. Following this, Amer's stock price...
2025-10-06 4:45 PM EDT
Class Action Alert: Levi & Korsinsky Reminds Semler Scientific, Inc. (SMLR) Investors of October 28, 2025 Deadline
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your Semler Scientific, Inc. (NASDAQ: SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=171093&wire=5&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...
2025-10-06 4:25 PM EDT
Securities Fraud Class Action Filed Against C3.ai, Inc. (AI) - Levi & Korsinsky Reminds Investors of October 21, 2025
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your C3.ai, Inc. (NYSE: AI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=171092&wire=5&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-06 4:20 PM EDT
Levi & Korsinsky Notifies Nutex Health Inc. (NUTX) Investors - Lead Plaintiff Deadline on October 21, 2025
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your Nutex Health Inc. (NASDAQ: NUTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=171091&wire=5&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-06 4:14 PM EDT
Securities Lawsuit Alert: Snap Inc. (SNAP) - Contact Levi & Korsinsky Before October 20, 2025
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your Snap Inc. (NYSE: SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=171090&wire=5&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-06 4:01 PM EDT
October 25, 2025 Deadline: Join Class Action Lawsuit Against LifeMD, Inc. (LFMD) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your LifeMD, Inc. (NASDAQ: LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=171089&wire=5&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-06 3:47 PM EDT
Class Action Lawsuit Alert: Levi & Korsinsky Reminds KBR, Inc. (KBR) Investors of November 18, 2025 Deadline
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your KBR, Inc. (NYSE: KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=171088&wire=5&utm_campaign=16 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-06 3:28 PM EDT
Charter Communications, Inc. (CHTR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 14, 2025 Deadline
New York, New York--(Newsfile Corp. - October 6, 2025) - If you suffered a loss on your Charter Communications, Inc. (NASDAQ: CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/charter-communications-inc-lawsuit-submission-form?prid=170968&wire=5&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-10-06 8:54 AM EDT
Levi & Korsinsky Investigates Possible Securities Fraud by MoonLake Immunotherapeutics (MLTX)
New York, New York--(Newsfile Corp. - October 6, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ: MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin condition, hidradenitis suppurativa, failed to meet that one of its late-stage trials. Specifically,...
2025-10-06 8:51 AM EDT
Investors in RCI Hospitality Holdings, Inc. (RICK): Protect Your Rights - Contact Levi & Korsinsky Before November 20, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ: RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=170767&wire=5&utm_campaign=11 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of...
2025-10-03 4:56 PM EDT
Fluor Corporation (FLR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of November 14, 2025 Deadline
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Fluor Corporation (NYSE: FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=170766&wire=5&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-03 4:55 PM EDT
Contact Levi & Korsinsky by October 20, 2025 to Join Class Action Against Snap Inc. (SNAP)
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Snap Inc. (NYSE: SNAP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/snap-inc-lawsuit-submission-form-2?prid=170765&wire=5&utm_campaign=10 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:38 PM EDT
Lost Money on PubMatic, Inc. (PUBM)? Urged to Join Class Action Before October 20, 2025 - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your PubMatic, Inc. (NASDAQ: PUBM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pubmatic-inc-lawsuit-submission-form?prid=170764&wire=5&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:35 PM EDT
Join Class Action to Recover Losses from Altimmune, Inc. (ALT) - Contact Levi & Korsinsky Before October 6, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Altimmune, Inc. (NASDAQ: ALT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/altimmune-inc-lawsuit-submission-form-2?prid=170763&wire=5&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder...
2025-10-03 4:33 PM EDT
October 25, 2025 Deadline Approaching: Join Class Action Against LifeMD, Inc. (LFMD) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your LifeMD, Inc. (NASDAQ: LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=170762&wire=5&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:24 PM EDT
Levi & Korsinsky Notifies Dow Inc. (DOW) Investors - Lead Plaintiff Deadline on October 28, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Dow Inc. (NYSE: DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=170761&wire=5&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocates.
2025-10-03 4:22 PM EDT
Levi & Korsinsky Urges Semler Scientific, Inc. (SMLR) Shareholders to Act Before Lead Plaintiff Deadline October 28, 2025
New York, New York--(Newsfile Corp. - October 3, 2025) - If you suffered a loss on your Semler Scientific, Inc. (NASDAQ: SMLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/semler-scientific-inc-lawsuit-submission-form?prid=170760&wire=5&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced...
2025-10-03 3:56 PM EDT
Investigation Underway: MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Over Securities Law Violations
New York, New York--(Newsfile Corp. - October 3, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ: MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental immune disease drug sonelokimab for the treatment of a chronic inflammatory skin condition, hidradenitis suppurativa, failed to meet that one of its late-stage trials. Specifically,...
2025-10-03 3:54 PM EDT